Zentalis Pharmaceuticals ... (ZNTL)
NASDAQ: ZNTL
· Real-Time Price · USD
1.59
0.11 (7.43%)
At close: Aug 15, 2025, 3:59 PM
1.56
-2.19%
After-hours: Aug 15, 2025, 07:25 PM EDT
Zentalis Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -26.87M | -48.28M | -47.47M | -40.19M | -88.28M | 10.07M | -60.92M | -55.54M | -112.56M | -63.26M | -54.98M | -54.5M | -68.39M | -59.24M | -50.09M | -10.49M | -55.06M | -50.44M |
Depreciation & Amortization | 160K | 262K | 317K | 321K | 327K | 324K | 337K | 348K | 344K | 360K | 359K | 375K | 348K | 344K | 209K | 137K | 119K | 79K |
Stock-Based Compensation | 6.29M | 6.49M | 31.36M | 10.36M | 12.71M | 12.83M | 13.88M | 13.87M | 13.34M | 13.73M | 9.61M | 10.32M | 16.76M | 10.15M | 8.47M | 7.66M | 9.92M | 9.69M |
Other Working Capital | 2.26M | 777K | 486K | 4.75M | 2.3M | -1.06M | -129K | -1.55M | -770K | -2.61M | -12.11M | 3.17M | -1.61M | -2.77M | 1.47M | -392K | -515K | 782K |
Other Non-Cash Items | -5.95M | 7.14M | -16.83M | -16.75M | 26M | -58.89M | -10K | -2.12M | 25.52M | 4M | 4.47M | 1.1M | 5.19M | 1.97M | 1.99M | -49.7M | -256K | -239K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | -4.16M | n/a | -756K | -97K | -769K | -125K | 74K | -74K | 36K | 6.3M | 488K | 543K |
Change in Working Capital | -8.33M | 1.75M | -7.08M | 2.21M | 14.1M | -16.3M | 10.27M | 4.78M | -5.16M | -4.02M | 3.98M | 9.63M | 2.99M | -3.35M | 2.37M | 12.61M | -1.32M | 2.9M |
Operating Cash Flow | -34.71M | -32.64M | -39.7M | -44.05M | -35.14M | -51.97M | -40.6M | -38.66M | -79.28M | -49.28M | -37.33M | -33.2M | -43.03M | -50.2M | -37.02M | -33.49M | -46.11M | -37.47M |
Capital Expenditures | n/a | n/a | n/a | n/a | -181K | -40K | -173K | -91K | -319K | n/a | -160K | -1.66M | -278K | -450K | -2.19M | -2.66M | -819K | -436K |
Cash Acquisitions | 564K | 5K | n/a | -65K | 65K | n/a | 41.89K | 117.36K | -73.25K | n/a | 11.73K | -21.68K | 141.82K | n/a | n/a | -14.32M | n/a | n/a |
Purchase of Investments | -40.19M | -19.53M | -39.22M | -59.24M | -19.39M | -10.12M | -95.99M | -264.11M | -125.21M | -63.88M | -125.98M | -129.6M | -198.32M | -79.25M | -83.22M | -202.47M | -23.38M | -54.43M |
Sales Maturities Of Investments | 70M | 60M | 71.5M | 107.48M | 54M | 71.7M | 54.1M | 146.75M | 198.46M | 106M | 114.25M | 151.28M | 56.5M | 99.5M | 128.68M | 78.01M | 90.8M | 68.33M |
Other Investing Acitivies | n/a | n/a | n/a | 65K | n/a | n/a | -41.89K | -117.36K | 73.25K | 42.12K | -11.73K | 21.68K | -141.82K | 20.25M | 45.46M | -14.32M | 67.42M | 13.89M |
Investing Cash Flow | 30.38M | 40.48M | 32.28M | 48.24M | 34.49M | 61.55M | -42.06M | -117.45M | 72.93M | 42.12M | -11.89M | 20.02M | -142.1M | 19.8M | 43.27M | -141.44M | 66.6M | 13.46M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | 349K | n/a | n/a | -241K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -1.15M | 386K | -386K | n/a |
Financial Cash Flow | n/a | 189K | n/a | 92K | 9K | 7K | n/a | 309K | 236.62M | 373K | 49.74M | 589K | 209.46M | 1.26M | 12.27M | 166.57M | -316K | n/a |
Net Cash Flow | -4.33M | 8.03M | -7.42M | 4.29M | -640K | 9.58M | -82.71M | -155.81M | 230.28M | -6.79M | 518K | -12.59M | 24.33M | -29.14M | 18.51M | -8.36M | 20.17M | -24.01M |
Free Cash Flow | -34.71M | -32.64M | -39.7M | -44.05M | -35.32M | -52.01M | -40.77M | -38.76M | -79.59M | -49.28M | -37.49M | -34.86M | -43.3M | -50.65M | -39.21M | -36.15M | -46.93M | -37.91M |